5-170794274-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_014211.3(GABRP):āc.216C>Gā(p.Ile72Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000151 in 1,459,908 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 29)
Exomes š: 0.000015 ( 0 hom. )
Consequence
GABRP
NM_014211.3 missense
NM_014211.3 missense
Scores
3
10
6
Clinical Significance
Conservation
PhyloP100: -0.0320
Genes affected
GABRP (HGNC:4089): (gamma-aminobutyric acid type A receptor subunit pi) The gamma-aminobutyric acid (GABA) A receptor is a multisubunit chloride channel that mediates the fastest inhibitory synaptic transmission in the central nervous system. The subunit encoded by this gene is expressed in several non-neuronal tissues including the uterus and ovaries. This subunit can assemble with known GABA A receptor subunits, and the presence of this subunit alters the sensitivity of recombinant receptors to modulatory agents such as pregnanolone. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GABRP | NM_014211.3 | c.216C>G | p.Ile72Met | missense_variant | 4/10 | ENST00000265294.9 | NP_055026.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD3 genomes
Cov.:
29
GnomAD3 exomes AF: 0.0000398 AC: 10AN: 251112Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135714
GnomAD3 exomes
AF:
AC:
10
AN:
251112
Hom.:
AF XY:
AC XY:
3
AN XY:
135714
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000151 AC: 22AN: 1459908Hom.: 0 Cov.: 29 AF XY: 0.0000138 AC XY: 10AN XY: 726398
GnomAD4 exome
AF:
AC:
22
AN:
1459908
Hom.:
Cov.:
29
AF XY:
AC XY:
10
AN XY:
726398
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 29
GnomAD4 genome
Cov.:
29
Bravo
AF:
ExAC
AF:
AC:
5
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.216C>G (p.I72M) alteration is located in exon 4 (coding exon 3) of the GABRP gene. This alteration results from a C to G substitution at nucleotide position 216, causing the isoleucine (I) at amino acid position 72 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;.;D;D;D
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D;D;D;D;D
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;.;.;L;L;.;.
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;D;N;N;N;N
REVEL
Pathogenic
Sift
Uncertain
D;D;D;D;D;D;T
Sift4G
Benign
T;D;T;D;D;T;T
Polyphen
1.0
.;.;.;D;D;D;.
Vest4
0.83, 0.82, 0.84, 0.83
MutPred
Gain of catalytic residue at I72 (P = 0.0119);Gain of catalytic residue at I72 (P = 0.0119);Gain of catalytic residue at I72 (P = 0.0119);Gain of catalytic residue at I72 (P = 0.0119);Gain of catalytic residue at I72 (P = 0.0119);Gain of catalytic residue at I72 (P = 0.0119);Gain of catalytic residue at I72 (P = 0.0119);
MVP
MPC
0.57
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at